Filing Details

Accession Number:
0001567619-20-016270
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-01 21:44:15
Reporting Period:
2020-08-31
Accepted Time:
2020-09-01 21:44:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1051578 I E David Pyott 105 Digital Drive
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-31 11,900 $78.22 29,840 No 4 P Direct
Common Stock Acquisiton 2020-08-31 900 $78.84 30,740 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price in column 4 is the weighted average price. The actual purchase price paid ranged from $77.78 to $78.76. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.
  2. The price in column 4 is the weighted average price. The actual purchase price paid ranged from $78.78 to $78.91. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.